Home  »  Company   »  Tenax Therapeutics Inc. (NASDAQ: TENX) Wednesday...

Tenax Therapeutics Inc. (NASDAQ: TENX) Wednesday’s Performance: Up 21.05% From The Lows, Now What?

Tenax Therapeutics Inc. (NASDAQ:TENX)’s traded shares stood at 6.15 million during the last session, with the company’s beta value hitting 2.24. At the close of trading, the stock’s price was $0.57, to imply an increase of 4.40% or $0.02 in intraday trading. The TENX share’s 52-week high remains $17.00, putting it -2882.46% down since that peak but still an impressive 21.05% since price per share fell to its 52-week low of $0.45. The company has a valuation of $4.29M, with an average of 15.27 million shares in intraday trading volume over the past 10 days and average of 3.58 million shares over the past 3 months.

Analysts have given a consensus recommendation of a Buy for Tenax Therapeutics Inc. (TENX), translating to a mean rating of 2.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give TENX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$1.7.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Tenax Therapeutics Inc. (NASDAQ:TENX) trade information

After registering a 4.40% upside in the last session, Tenax Therapeutics Inc. (TENX) has traded red over the past five days. The stock hit a weekly high of 0.7880 this Wednesday, 03/15/23, jumping 4.40% in its intraday price action. The 5-day price performance for the stock is 0.69%, and -47.80% over 30 days. With these gigs, the year-to-date price performance is -74.46%. Short interest in Tenax Therapeutics Inc. (NASDAQ:TENX) saw shorts transact 0.1 million shares and set a 0.4 days time to cover.

Analysts on Wall Street suggest a consensus price target of $6.00, implying an increase of 90.5% to the stock’s current value. The extremes give us $6.00 and $6.00 for target low and target high price respectively. As such, TENX has been trading -952.63% off suggested target high and -952.63% from its likely low.

Tenax Therapeutics Inc. (TENX) estimates and forecasts

Looking at statistics comparing Tenax Therapeutics Inc. share performance against respective industry, we note that the company has outperformed competitors. Tenax Therapeutics Inc. (TENX) shares are -86.45% down over the last 6 months, with its year-to-date growth rate higher than industry average at 71.93% against 9.90%.

TENX Dividends

Tenax Therapeutics Inc. has its next earnings report out between March 27 and March 31. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Tenax Therapeutics Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Tenax Therapeutics Inc. (NASDAQ:TENX)’s Major holders

Tenax Therapeutics Inc. insiders hold 4.58% of total outstanding shares, with institutional holders owning 4.02% of the shares at 4.21% float percentage. In total, 4.02% institutions holds shares in the company, led by Armistice Capital, LLC. As of Sep 29, 2022, the company held over 98294.0 shares (or 4.26% of shares), all amounting to roughly $0.33 million.

The next major institution holding the largest number of shares is Blackrock Inc. with 23953.0 shares, or about 1.04% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $81440.0.

We also have Vanguard Extended Market Index Fund and Fidelity NASDAQ Composite Index Fund as the top two Mutual Funds with the largest holdings of the Tenax Therapeutics Inc. (TENX) shares. Going by data provided on Sep 29, 2022, Vanguard Extended Market Index Fund holds roughly 8690.0 shares. This is just over 0.38% of the total shares, with a market valuation of $29546.0. Data from the same date shows that the other fund manager holds a little less at 1520.0, or 0.07% of the shares, all valued at about 4499.0.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts